PHARMACYTE BIOTECH, INC. Deferred Tax Assets, Net of Valuation Allowance, Current
PHARMACYTE BIOTECH, INC. (PMCB) had Deferred Tax Assets, Net of Valuation Allowance, Current of $0 as of 2020-04-30, per its 10-K filed 2020-08-13.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2020-08-13
- 2020-04-30: Deferred Tax Assets, Net of Valuation Allowance, Current $0.00.
- 2019-04-30: Deferred Tax Assets, Net of Valuation Allowance, Current $0.00.
- 2018-04-30: Deferred Tax Assets, Net of Valuation Allowance, Current $0.00.
- 2017-04-30: Deferred Tax Assets, Net of Valuation Allowance, Current $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current |
|---|---|
| 2020-04-30 | $0.00 10-K · filed 2020-08-13 |
| 2019-04-30 | $0.00 10-K · filed 2020-08-13 |
| 2018-04-30 | $0.00 10-K · filed 2019-08-13 |
| 2017-04-30 | $0.00 10-K · filed 2018-07-20 |
| 2016-04-30 | $0.00 10-K · filed 2017-07-27 |
| 2015-04-30 | $0.00 10-K · filed 2016-07-29 |
| 2014-04-30 | $0.00 10-K/A · filed 2016-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |